Position in RCEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$55,500
-$35,925 QoQ
Shares Held
15,000
-43.4% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $164,620,206 across 32 Medical Devices names. RCEL ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
76,155 | $25,023,771 | |
| 2 | MASI |
Masimo Corp
|
126,082 | $22,426,205 | |
| 3 | BSX |
Boston Scientific Corp
|
325,476 | $20,423,619 | |
| 4 | GMED |
Globus Medical Inc
|
225,000 | $19,386,000 | |
| 5 | PEN |
Penumbra Inc
|
56,623 | $18,593,294 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
147,350 | $13,323,387 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
|
28,400 | $7,916,500 | |
| 8 | STE |
STERIS plc
|
22,700 | $5,019,651 |
All Filings in RCEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,500 | 15,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $91,425 | 26,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $178,850 | 35,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $185,150 | 35,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||